Virios Therapeutics Llc News

VIRIDelisted Stock  USD 3.95  0.00  0.00%   
Under 55% of Virios Therapeutics' investor base is interested to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are impartial regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
  
over three months ago at news.google.com         
Virios Therapeutics ratifies auditor, elects directors - Investing.com India
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Gregory Duncan of 801 shares of Virios Therapeutics at 7.8 subject to Rule 16b-3
Macroaxis News
over three months ago at investing.com         
Virios Therapeutics receives Nasdaq compliance extension
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by De La Rosa Abel of 5250 shares of Virios Therapeutics subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Virios Therapeutics and Exicure Critical Contrast - Defense World
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Angela Walsh of 2000 shares of Virios Therapeutics at 4.575 subject to Rule 16b-3
Macroaxis News
over six months ago at benzinga.com         
Virios Therapeutics Announces Closing of 1.7 Million Public Offering of Common Stock to Commence Pre...
benzinga news
over six months ago at finance.yahoo.com         
Virios Therapeutics Announces Closing of 1.7 Million Public Offering of Common Stock to Commence Pre...
Yahoo News
over six months ago at globenewswire.com         
Virios Therapeutics Announces Closing of 1.7 Million Public Offering of Common Stock to Commence Pre...
Macroaxis News: globenewswire.com
over six months ago at benzinga.com         
Virios Therapeutics Announces Pricing of 1.7 Million Public Offering of Common Stock to Commence Pre...
benzinga news
over six months ago at investorplace.com         
Red Lobster Bankruptcy What Happened to the Popular Seafood Chain?
sbwire news
over six months ago at globenewswire.com         
Virios Therapeutics Announces Pricing of 1.7 Million Public Offering of Common Stock to Commence Pre...
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
Virios Therapeutics Announces Pricing of 1.7 Million Public Offering of Common Stock to Commence Pre...
Yahoo News
over six months ago at news.google.com         
Virios Therapeutics Announces Pricing of 1.7 Million Public Offering of Common Stock to Commence Pre...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Virios Therapeutics that are available to investors today. That information is available publicly through Virios media outlets and privately through word of mouth or via Virios internal channels. However, regardless of the origin, that massive amount of Virios data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Virios Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Virios Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Virios Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Virios Therapeutics alpha.

Virios Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
08/01/2024
2
VIRI Stock Earnings Virios Therapeutics Beats EPS for Q2 2024
08/08/2024
3
VIRI Enrollment Complete in Phase 2a Long COVID Trial Results Expected in October 2024
08/13/2024
4
Virios Therapeutics stock hits 52-week low at 0.15 - Investing.com
10/01/2024
5
Virios Therapeutics Soars Over 33 percent on Merger Announcement
10/08/2024
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in Virios Stock

If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments